The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Antiplatelet therapy after percutaneous coronary intervention
April 1, 2022 | 10.4244/EIJ-D-21-00904
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy
Overtchouk P,
Barthélémy O,
Hauguel-Moreau M,
Guedeney P,
Rouanet S,
Zeitouni M,
Silvain J,
Collet J,
Vicaut E,
Zeymer U,
Desch S,
Thiele H,
Montalescot G
February 5, 2021 | 10.4244/EIJ-D-20-00139
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
Collet J,
Kerneis M,
Lattuca B,
Yan Y,
Cayla G,
Silvain J,
Lapostolle F,
Ecollan P,
Diallo A,
Vicaut E,
Hamm C,
van't Hof A,
Montalescot G
September 20, 2018 | 10.4244/EIJ-D-18-00182
The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
Bellemain-Appaix A,
Begue C,
Bhatt D,
Ducci K,
Harrington R,
Roe M,
Wiviott SD,
Cucherat M,
Silvain J,
Collet J,
Bernasconi F,
Montalescot G
May 20, 2018 | 10.4244/EIJ-D-17-00852
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support
Overtchouk P,
Pascal J,
Lebreton G,
Hulot J-S,
Luyt C-E,
Combes A,
Kerneis M,
Silvain J,
Barthelemy O,
Leprince P,
Brechot N,
Montalescot G,
Collet J
April 6, 2018 | 10.4244/EIJ-D-17-01014
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures
Guedeney P,
Hammoudi N,
Duthoit G,
Yan Y,
Silvain J,
Pousset F,
Isnard R,
Redheuil A,
Kerneis M,
Collet J,
Montalescot G
November 20, 2017 | 10.4244/EIJ-D-17-00518
Antithrombotic therapy in TAVI patients: changing concepts
September 17, 2015 | 10.4244/EIJV11SWA28
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
Capodanno D,
Lip G,
Windecker S,
Huber K,
Kirchhof P,
Boriani G,
Lane D,
Gilard M,
Collet J,
Valgimigli M,
Byrne R
January 22, 2015 | 10.4244/EIJV10I9A174
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker S,
Kolh P,
Alfonso F,
Collet J,
Cremer J,
Falk V,
Filippatos G,
Hamm C,
Head S,
Jüni P,
Kappetein AP,
Kastrati A,
Knuuti J,
Landmesser U,
Laufer G,
Neumann F,
Richter D,
Schauerte P,
Uva M,
Stefanini G,
Taggart D,
Torracca L,
Valgimigli M,
Wijns W,
Witkowski A
January 22, 2015 | 10.4244/EIJY14M09_01
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
September 15, 2013 | 10.4244/EIJV9SSA9
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022